MoneyWorks4Me

Biocon informs about investor release

30 Dec 2024 Evaluate

Biocon has informed that it enclosed a notification titled ‘Biocon Biologics has fulfilled its obligations towards all deferred milestones under the acquisition agreement with Viatris. This also marks, as full and final remittance of considerations from Biocon Biologics toward Viatris for the acquisition.] The above information will also be available on the website of the Company at www.biocon.com.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..